The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Circulating tumor DNA (ctDNA) as a molecular monitoring tool in metastatic breast cancer (MBC).
Laura Katherine Austin
No relevant relationships to disclose
Paolo Fortina
No relevant relationships to disclose
Dragan Sebisanovic
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
LaiMun Siew
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Aubrey Zapanta
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
AmirAli Talasaz
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Massimo Cristofanilli
No relevant relationships to disclose